BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen R, Zhang H, Ma T, Xue H, Miao Z, Chen L, Shi X. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation. Bioorganic & Medicinal Chemistry Letters 2019;29:2635-7. [DOI: 10.1016/j.bmcl.2019.07.041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharma A, Agrahari AK, Rajkhowa S, Tiwari VK. Emerging impact of triazoles as anti-tubercular agent. Eur J Med Chem 2022;238:114454. [PMID: 35597009 DOI: 10.1016/j.ejmech.2022.114454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chowdhary S, Shalini, Arora A, Kumar V. A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs). Pharmaceuticals 2022;15:536. [DOI: 10.3390/ph15050536] [Reference Citation Analysis]
3 Suaifan GARY, Mohammed AAM, Alkhawaja BA. Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines. Molecules 2022;27:1658. [PMID: 35268759 DOI: 10.3390/molecules27051658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cheke RS, Patil VM, Firke SD, Ambhore JP, Ansari IA, Patel HM, Shinde SD, Pasupuleti VR, Hassan MI, Adnan M, Kadri A, Snoussi M. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery. Pharmaceuticals 2022;15:272. [DOI: 10.3390/ph15030272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Malah TE, Farag H, Hemdan BA, Abdel Mageid RE, Abdelrahman MT, El-manawaty MA, Nour HF. Synthesis, in vitro antimicrobial evaluation, and molecular docking studies of new isatin-1,2,3-triazole hybrids. Journal of Molecular Structure 2022;1250:131855. [DOI: 10.1016/j.molstruc.2021.131855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Kancharla SK, Birudaraju S, Pal A, Krishnakanth Reddy L, Reddy ER, Vagolu SK, Sriram D, Bonige KB, Korupolu RB. Synthesis and biological evaluation of isatin oxime ether-tethered aryl 1 H -1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis. New J Chem 2022;46:2863-74. [DOI: 10.1039/d1nj05171g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dhameliya TM, Bhakhar KA, Gajjar ND, Patel KA, Devani AA, Hirani RV. Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions. Journal of Molecular Structure 2022;1248:131473. [DOI: 10.1016/j.molstruc.2021.131473] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
8 Tan Z, Deng J, Ye Q, Zhang Z. Triazole-containing hybrids with anti-Mycobacterium tuberculosis potential - Part I: 1,2,3-Triazole. Future Med Chem 2021;13:643-62. [PMID: 33619989 DOI: 10.4155/fmc-2020-0301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kumar R, Takkar P. Repositioning of Isatin hybrids as novel anti-tubercular agents overcoming pre-existing antibiotics resistance. Med Chem Res 2021;30:847-76. [DOI: 10.1007/s00044-021-02699-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Yagiz G, Noma SAA, Altundas A, Al-Khafaji K, Taskin-Tok T, Ates B. Synthesis, inhibition properties against xanthine oxidase and molecular docking studies of dimethyl N-benzyl-1H-1,2,3-triazole-4,5-dicarboxylate and (N-benzyl-1H-1,2,3-triazole-4,5-diyl)dimethanol derivatives. Bioorg Chem 2021;108:104654. [PMID: 33493930 DOI: 10.1016/j.bioorg.2021.104654] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
11 Elsayed ZM, Eldehna WM, Abdel-Aziz MM, El Hassab MA, Elkaeed EB, Al-Warhi T, Abdel-Aziz HA, Abou-Seri SM, Mohammed ER. Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria. J Enzyme Inhib Med Chem 2021;36:384-93. [PMID: 33406941 DOI: 10.1080/14756366.2020.1868450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
12 Bremner J. Single Molecule Non-cleavable Multiply Active Antibacterials. Multiple Action-Based Design Approaches to Antibacterials 2021. [DOI: 10.1007/978-981-16-0999-2_3] [Reference Citation Analysis]
13 Nath R, Pathania S, Grover G, Akhtar MJ. Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship. Journal of Molecular Structure 2020;1222:128900. [DOI: 10.1016/j.molstruc.2020.128900] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
14 Venugopala KN, Kandeel M, Pillay M, Deb PK, Abdallah HH, Mahomoodally MF, Chopra D. Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4H-1,2,4-Triazole-3-Thiol and Its Schiff Bases: Computational Input and Molecular Dynamics. Antibiotics (Basel) 2020;9:E559. [PMID: 32878018 DOI: 10.3390/antibiotics9090559] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]